Latest News for: psilocin

Edit

Lobe Sciences and Alera Pharma Announce Issuance of U.S. Patent for Conjugated Psilocin™

Business Wire 02 Oct 2024
(“Lobe Sciences” or the “Company”) (CSE ... Patent number 12,102,616 titled “Psilocin Mucate”.
Edit

Illegal drug found in Diamond Shruumz candies linked to severe illnesses

Ars Technica 19 Jul 2024
The new finding of psilocin in the products, published by researchers at the University of Virginia, adds to growing concern about psychedelic mushroom candies generally.
Edit

Enveric Biosciences Signs $66.5 Million Non-Binding Term Sheet with MindBio Therapeutics to Out-License Novel Psilocin ...

Corsicana Daily Sun 15 May 2024
MindBio to develop the novel psilocin prodrug for neuropsychiatric indications utilizing microdosing to reduce or eliminate hallucinogenic impact of psychedelic compounds ....
Edit

Enveric Biosciences Signs $66.5 Million Non-Binding Term Sheet with MindBio Therapeutics to Out-License Novel Psilocin Prodrug Candidate for Mental Health Disorders

Pharmiweb 14 May 2024
MindBio to develop the novel psilocin prodrug for neuropsychiatric indications utilizing microdosing to reduce or eliminate hallucinogenic impact of psychedelic compounds ... psilocin at varying rates.
Edit

Tryp Therapeutics Announces Significant Milestone in Its Clinical Trial Program for Trp-8803 (IV-infused Psilocin)

Pharmiweb 08 Jan 2024
This study is designed to determine the optimal blood levels of psilocin needed to achieve the targeted psychedelic state ... TRP-8803 provides a proprietary formulation of psilocin administered by IV infusion.
Edit

Lobe Sciences Provides Update on L-130 Oral Psilocin Compound

Business Wire 05 Dec 2023
VANCOUVER, British Columbia--(BUSINESS WIRE)--Lobe Sciences Reports 12 Months Stability for Lead Psilocin Drug Candidate (L-130) ... .
Edit

Enveric Biosciences Announces Manuscript Detailing the Development of Novel Psilocin Prodrugs for the Treatment of ...

Business Wire 22 May 2023
... development of novel psilocin prodrug derivatives targeting treatment of mental health disorders.
Edit

Enveric Biosciences Receives Notice of Allowance from USPTO for Novel Prodrug of Psilocin

Business Wire 18 May 2023
... involving EB-373, the Company’s new chemical entity (NCE) psilocin prodrug being developed fo .
Edit

Enveric Biosciences Shares Rise 40% After Notice of Allowance for Psilocin U.S. Patent

Market Watch 18 May 2023
Patent and Trademark Office for a patent application involving EB-373, its new chemical entity psilocin prodrug being developed for the treatment of anxiety disorder.

Most Viewed

×